Shares of Avidity Biosciences, Inc. (RNA) fell 20% in the pre-market session on Thursday after the company announced that it intends to offer and sell $500 million of shares of its common stock in an ...
As per the deal, Avidity shareholders will receive $72.00 per share in cash at closing. The price reflects a roughly 46% premium over the company’s October 24, 2025, closing price of $49.15 and about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results